$LBTD Acquisition and Expansion Plans of Focal Point

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
131
$LBTD Acquisition and Expansion Plans of Focal Point Healthcare, a CLIA-Authorized Lab for $LBTD; Facilitating Services for Netflix, Amazon Prime, HBO, CBS, Discovery

Lotus Bio-Technology Development Corp. (OTCMKTS: LBTD)

We have a remarkable business with incredible revenue & an extremely competent management team. We have carefully designed our business in such a way that we feel confident success is our only option”— LBTD President Hoyt ChristopherCAVE CREEK, ARIZONA, UNITED STATES, January 10, 2023 /EINPresswire.com/ -- Acquisition and Expansion Plans of Focal Point Healthcare, a CLIA-Authorized Lab for $LBTD; Facilitating Services for Netflix, Amazon Prime, HBO, CBS, Discovery, NBC’s Peacock, Autozone + More: Lotus Bio-Technology: (Stock Symbol LBTD)

 Digital Healthcare Company Focused on Covid Testing Services for Important Wide Client Base.

 New Management with Expansive Vision for 2023 and Beyond.

 Nationwide Mobile Covid Testing Services for Business, School, Pre-Flight, and Other Key Safety Needs.

 Focused on Acquiring and Developing Companies and Technology that Emphasize a User-Friendly Approach.

 Leadership Team Represents a Unique Blend of Entertainment and Medical Professionals who came out of COVID-19 Testing for TV and Film Productions.

 Subsidiary Focal Point’s Revenue From Medical Testing Exceeds 13 Million for 2021 and 2022.

Lotus Bio-Technology Development Corp. (OTC: LBTD) is committed to improving healthcare and advancing diagnostics through technology development and market acquisition. LBTD currently manages a portfolio of state-of-the-art technologies and innovative companies that are successfully modernizing medicine and prioritizing a user-friendly approach to patient care.

LBTD Subsidiary Focal Point Healthcare offers a nationwide range of mobile Covid Testing which can be sent out within 24 hours of notice. LBTD has already established multiple locations of operation in California, Arizona, Nevada, and Florida. Current services include the following:
Drive-Thru Testing

LBTD Drive Thru testing does not require an appointment. LBTD offers two types of tests, a Rapid Antibody test (finger prick) and a PCR (nasal swab).
A licensed clinician performs the Rapid Antibody test (finger prick), and has it interpreted by a LBTD Medical Director. The results will be sent via email to you within 30-45 minutes.

The PCR test (nasal swab) is performed by a licensed clinician and the specimen will be sent to one of the company’s laboratories. Results take 24-48 hours to be sent out via email.

School Districts

Board Certified in Pathology Medical Director.

On-the-ground, experienced production representative to establish a testing base camp and implement protocols at each studio or location.

LBTD Focal Point Health Care owns multiple labs to ensure quick results & fast turn-around to keep productions on time and on budget.

LBTD labs and testing services are licensed in all 50 US States & Canada and have been granted Emergency Use Authorization (EAU) by the FDA for SARS-CoV-2 tests.

Preflight Testing

LBTD Focal Point Healthcare Services has partnered with a number of airlines and airports which require preflight Covid testing. By guaranteeing a timely turnaround time, LBTD makes sure that all customers are ready in time for their flights. Results can be sent directly to the customer to bring to the airport.
Corporate Partnerships

LBTD Focal Point Healthcare Services has partnered with a number of businesses, professional sports teams, and facilities. LBTD has streamlined the process of collecting hundreds of samples and getting results in a timely manner. LBTD understands the importance and urgency of administering testing to our corporate accounts to ensure all employees are safe and healthy. LBTD offers flexible dates and times for service.

With LBTD management having experience and key connections in the entertainment field, the company has been performing important testing services to keep some very high-profile shows running safely and on a timely basis.

The notable list of entertainment products that LBTD has tested for:

Netflix

My Unorthodox Life

Bling Empire LA

Bling Empire NYC

Amazon

Tampa Baes

CBS/VIACOM

Bar Rescue

Discovery

Ghost Town

Revolt

Michelle Obama Special

DISCLAIMER: CAP/FrontPageStocks/CorporateAds.com (CA) is a third-party publisher and news dissemination service provider. CAP/FPS/CA is NOT affiliated in any manner with any company mentioned herein. CAP/FPS/CA is a news dissemination solutions provider and is NOT a registered broker/dealer/analyst/adviser, holds no investment licenses, and may NOT sell, offer to sell or offer to buy any security. CAP/FPS/CA’s market updates, news alerts, and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or the opinion of the writer. CAP/FPS/ CA is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. CAP/FPS/CA has been compensated $500 by a third party for the dissemination of this article.

Disclaimer/Safe Harbor:

These news releases and postings may contain forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In light of these uncertainties, the forward-looking events referred to in this release might not occur.

SOURCE: CorporateAds.com
Hoyt Christopher, CEO
Lotus Bio-Technology Development Corp.
+1 778-814-7729
email us here
Visit us on social media:
Instagram: https://www.instagram.com/lbtdholdings/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 371

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 409

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 298

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 229

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 177

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 28

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 214

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 180

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 298

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 353

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading

Top 5 Most Recently Viewed Articles

Transocean Ltd. Scheduled Earnings Conference Call for Q3 2024

Updated Category News Views 52

Transocean Ltd. Earnings Release Announcement Transocean Ltd. has officially announced that it will be releasing its third quarter earnings for 2024. The earnings report is scheduled for Wednesday, October 30, 2024. This release is highly anticipated as it aims to provide stakeholders with insights regarding the company's performance in the offshore contract drilling...

Continue Reading
Stride, Inc. Faces Class Action as Investors Seek Justice

Updated Category News Views 151

Stride, Inc. Faces Securities Lawsuit Stride, Inc. (NYSE: LRN), a prominent educational service provider, finds itself embroiled in a class action lawsuit alleging serious violations of securities laws. Investors who feel wronged are encouraged to engage with experienced legal counsel to explore their options. The law firm Levi & Korsinsky, known for its adept handling of...

Continue Reading
Amazon's Prime Day and Golden Cross: A Bullish Outlook

Updated Category News Views 185

Amazon's Market Dynamics and Performance Insights In today's ever-evolving technology sector, companies often evaluate key performance indicators (KPIs) that forecast their future success. Amazon.com (NASDAQ: AMZN) exemplifies this, boasting a market capitalization of $2.3 trillion. Each year, Amazon's Prime Day is a highlight for online shoppers, offering discounts that...

Continue Reading
Previewing Lam Research's Upcoming Earnings Release

Updated Category News Views 152

Preparing for Lam Research's Earnings Announcement Lam Research (NASDAQ:LRCX) is gearing up for its next quarterly earnings report. Investors are anxious for an update, especially with anticipation building around the company’s performance. Understanding the upcoming earnings can provide crucial insights into Lam Research’s potential growth trajectory. What Analysts...

Continue Reading
AAR CORP. Announces Public Offering of 3 Million Shares

Updated Category News Views 272

AAR CORP. Pricing of Public Offering AAR CORP. ('AAR' or the 'Company') (NYSE: AIR) has officially announced the pricing of a significant underwritten public offering encompassing 3,000,000 shares of its common stock. The shares are being offered at a set price of $83.00 per share, with the underwriters given a 30-day option to acquire an extra 450,000 shares from AAR at...

Continue Reading